» Articles » PMID: 38786549

A Modern Approach to the Treatment of Traumatic Brain Injury

Overview
Specialty Pharmacology
Date 2024 May 24
PMID 38786549
Authors
Affiliations
Soon will be listed here.
Abstract

Traumatic brain injury manifests itself in various forms, ranging from mild impairment of consciousness to severe coma and death. Traumatic brain injury remains one of the leading causes of morbidity and mortality. Currently, there is no therapy to reverse the effects associated with traumatic brain injury. New neuroprotective treatments for severe traumatic brain injury have not achieved significant clinical success. A literature review was performed to summarize the recent interdisciplinary findings on management of traumatic brain injury from both clinical and experimental perspective. In the present review, we discuss the concepts of traditional and new approaches to treatment of traumatic brain injury. The recent development of different drug delivery approaches to the central nervous system is also discussed. The management of traumatic brain injury could be aimed either at the pathological mechanisms initiating the secondary brain injury or alleviating the symptoms accompanying the injury. In many cases, however, the treatment should be complex and include a variety of medical interventions and combination therapy.

Citing Articles

Lyophilized Small Extracellular Vesicles (sEVs) Derived from Human Adipose Stem Cells Maintain Efficacy to Promote Healing in Neuronal Injuries.

Jones B, Patel R, Wang B, Evans-Nguyen T, Patel N Biomedicines. 2025; 13(2).

PMID: 40002689 PMC: 11853053. DOI: 10.3390/biomedicines13020275.


The Current Update of Conventional and Innovative Treatment Strategies for Central Nervous System Injury.

Tsai M, Wu C, Wu C, Chen C Biomedicines. 2024; 12(8).

PMID: 39200357 PMC: 11351448. DOI: 10.3390/biomedicines12081894.


Calcium and Non-Penetrating Traumatic Brain Injury: A Proposal for the Implementation of an Early Therapeutic Treatment for Initial Head Insults.

ODay D Biomolecules. 2024; 14(7).

PMID: 39062567 PMC: 11274459. DOI: 10.3390/biom14070853.

References
1.
Fiani B, Covarrubias C, Wong A, Doan T, Reardon T, Nikolaidis D . Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes. Neurol Sci. 2021; 42(4):1345-1353. DOI: 10.1007/s10072-021-05089-2. View

2.
Lee J, Cho Y, Choi K, Kim W, Jang B, Shin H . Efficacy and safety of erythropoietin in patients with traumatic brain injury: A systematic review and meta-analysis. Am J Emerg Med. 2018; 37(6):1101-1107. DOI: 10.1016/j.ajem.2018.08.072. View

3.
Narouiepour A, Ebrahimzadeh-Bideskan A, Rajabzadeh G, Gorji A, Negah S . Neural stem cell therapy in conjunction with curcumin loaded in niosomal nanoparticles enhanced recovery from traumatic brain injury. Sci Rep. 2022; 12(1):3572. PMC: 8897489. DOI: 10.1038/s41598-022-07367-1. View

4.
Lin R, Kwok J, Crespo D, Fawcett J . Chondroitinase ABC has a long-lasting effect on chondroitin sulphate glycosaminoglycan content in the injured rat brain. J Neurochem. 2007; 104(2):400-8. DOI: 10.1111/j.1471-4159.2007.05066.x. View

5.
Zhu J, Zhou L, XingWu F . Tracking neural stem cells in patients with brain trauma. N Engl J Med. 2006; 355(22):2376-8. DOI: 10.1056/NEJMc055304. View